Rankings
▼
Calendar
LGVN Q4 2019 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$18M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$607,233
32.9% margin
Operating Income
-$474,035
-25.7% margin
Net Income
-$473,695
-25.7% margin
EPS (Diluted)
$-0.30
Cash Flow
Operating Cash Flow
$197,001
Free Cash Flow
$168,731
Stock-Based Comp.
$52,461
Balance Sheet
Total Assets
$11M
Total Liabilities
$6M
Stockholders' Equity
$4M
Cash & Equivalents
$2M
← FY 2019
All Quarters
Q1 2020 →